The Board of Directors of UCrest Berhad ("UCrest" or "the Company") is pleased to announce its audited results and strategic highlights for the financial year ended 31 May 2025 (FY2025) at its 28th Annual General Meeting (AGM), showcasing another year of strong growth, innovation in AI-driven healthcare, and expanding international partnerships.

Please refer to the attachment for the details of the announcement.

This announcement is dated 12 November 2025.